Treatment options for disseminated gastric cancer may include systemic or hyperthermic intraperitoneal chemotherapy, local radiation, and now more targeted therapies such as immune checkpoint and human epidermal growth factor receptor 2 (HER2) antibodies [2,3,4]. Here, ERBB2 is linked to gastric cancer.